Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Fanda

Anuj Kumar Fanda, Uttar Pradesh IN

Patent application numberDescriptionPublished
20100291225Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same - Disclosed herein is a stabilized sustained release pharmaceutical composition of bupropion hydrochloride and process for preparing the same, wherein said pharmaceutical composition comprising therapeutically effective amount of uncoated fine bupropion hydrochloride and pharmaceutically acceptable adjuvants, and wherein the composition is free of an acidic stabilizer and contains less than about 0.3% by weight of m-chlorobenzoic acid.11-18-2010

Anuj Kumar Fanda, Ghaziabad IN

Patent application numberDescriptionPublished
20100247646EXTENDED RELEASE TABLETS OF NISOLDIPINE - The present invention relates to extended release tablets comprising a core which comprises of nisoldipine, a rate-controlling hydrophilic polymer and optionally, an enteric agent. Such tablets may also be coated with a release rate-controlling coating comprising of a hydrophobic polymer or enteric agent or combinations thereof, in particular ethylcellulose, and Eudragits.09-30-2010

Anuj Kumar Fanda, Himachal Pradesh IN

Patent application numberDescriptionPublished
20100008987Modified Release Pharmaceutical Composition of Bupropion Hydrochloride - A delayed extended release pharmaceutical composition includes a compressed core containing an effective amount of bupropion or its pharmaceutically acceptable salt, a water-attractant polymer. The core is preferably devoid of a stabilizer. The core is surrounded by an extended release layer, which is free of plasticizer and pore-forming agent. The extended release layer is surrounded by a delayed release layer. Alternating coats of extended release layer and delayed release layer may follow. A preferred extended release layer includes ethylcellulose and hydroxypropyl cellulose or hydroxypropyl methylcellulose and a preferred delayed release layer includes methacrylic acid copolymer and hydroxypropyl methylcellulose phthalate, lactose and a combination of triethyl citrate and polyethylene glycol and talc. A method of preparing the delayed extended release bupropion hydrochloride containing pharmaceutical composition is also disclosed.01-14-2010